H ypertension is widely recognized as a public health menace but rarely treated as one. In many ways, the challenge of hypertension reflects a transition from classic public health strategies that have been applied to control microbial epidemics to a fully medicalized approach requiring individual doctor-patient encounters. One reason why hypertension has perhaps not been seen as a legitimate public health problem is the unavailability of good surveillance measures that can describe disease burden. Although we have abundant information about the relative risk associated with various levels of blood pressure and the benefit to be gained from treatment, it had not been possible until recently to relate levels of hypertension treatment and control in a specific population to rates of cardiovascular sequelae.Reasonable evidence suggests that increased levels of treatment of cardiovascular (CV) risk factors have been associated with declines in CV mortality. 1,2 The most recent estimates suggest that Ϸ60% of the CV decline can be explained by a combination of primary and secondary prevention. 2 Soon after antihypertensive therapy came into widespread use, the long-term decline in stroke mortality in the US increased from 1% to 2% per year. 1 Although stroke occurrence has been known to vary widely among countries, 3 there are inadequate data on blood pressure control from national surveys that have been collected in standardized fashion to assess fully its impact on CV disease rates. A comparison of the United States and Canada with several European countries, however, did suggest a strong relationship among mean blood pressure, the rate of hypertension control, and death from stroke. 4 In this issue of Hypertension, Redon et al 5 add an important new dimension to our understanding of the public health significance of blood pressure control. Using a standardized protocol, they sampled Ͼ7000 patients over the age of 60 years from primary care facilities in the 17 administrative regions in Spain. Using the Framingham model, they generated a multivariate estimate of stroke risk and averaged this by region. This aggregate measure of stroke risk was significantly related to observed stroke mortality by region, and, as might be expected, left ventricular hypertrophy and poor hypertension control were the primary factors driving this association. Overall, measured patient attributes accounted for almost two thirds of the variation in mortality. 5 As demonstrated in both the United States and the United Kingdom, these more recent estimates of hypertension control from Spain continue to show some modest improvement. 6,7 These data could form the basis of a regional "report card" that could be a useful tool in surveillance and control of CV diseases where medical services are provided on a comprehensive basis.The design used in this study is a specialized version of an "ecological" comparison. In this design, the observations generated by the average data from all of the geographic units being studied are assumed to apply to t...